03 May 2021 | NewsWebinar video now available - Australia’s COVID-19 vaccine program reset: navigating safety, acceptance and uptakeRead the full article
The COVID-19 vaccination program rollout began on 22 February 2021 in Australia with the Pfizer COVID-19 vaccine Comirnaty and AstraZeneca COVID-19 Vaccine. We have developed resources and dedicated web pages to support immunisation providers in the delivery of COVID-19 vaccines.
We have developed this page as a "one-stop shop" for a large number of resources that have been developed and new ones that continue to be developed related to the vaccination program. These include NCIRS resources, the Australian Government Department of Health resources for immunisation providers, the Australian Technical Advisory group on Immunisation (ATAGI) clinical advices, the Therapeutic Good Administration resources and individual state and territory resources, among others. We update this page regularly.
Access the web page here
We have answered some of the most frequently asked questions about various aspects of COVID-19 vaccines on this page, and we update this page regularly frequently.
Access the FAQ here
This page has a collection of resources that provide information on thrombosis with thrombocytopenia syndrome (TTS) after COVID-19 vaccination with AstraZeneca vaccine.
Access this web page here
AusVaxSafety is conducting active vaccine safety surveillance of the COVID-19 vaccines being used in Australia. AusVaxSafety surveillance uses a short survey sent by SMS/email to collect reports of adverse events following immunisation directly from the people receiving COVID-19 vaccines.
Access the latest AusVaxSafety COVID-19 vaccine safety data here
Accessing the Australian Immunisation Register
Specialist immunisation services
ASCIA Allergy, Immunodeficiency, Autoimmunity and COVID-19 Vaccination Position Statement
ASCIA Allergy and COVID-19 Vaccination - Guide for health professionals
ASCIA Immunodeficiency, Autoimmunity and COVID-19 Vaccination - Guide for health professionals
COVID-19 vaccines and cancer: Health professional guidance
COVID-19 vaccine development landscape
NCIRS COVID-19 response
NCIRS, Kids Research, Sydney Children’s Hospitals Network, Cnr Hawkesbury Rd & Hainsworth St, Westmead Locked Bag 4001, Westmead NSW 2145 Tel (612) 9845 1433 | Fax (612) 9845 1418 | ABN 53 188 579 090
We acknowledge that the National Centre for Immunisation Research and Surveillance (NCIRS) is on the land of the traditional owners the Aboriginal and Torres Strait Islander peoples, the First Australians, and recognise their culture, history, diversity and their deep connection to the land. Together, through research and partnership, we aim to move to a place of equity for all. NCIRS also acknowledges and pays respect to other Aboriginal and Torres Strait Islander nations from which our research, staff and community are drawn.
Copyright © 2021 NCIRS. All rights reserved
Our website meets the criteria for credibility and content as defined by the Global Advisory Committee on Vaccine Safety.
Stay updated with the latest from NCIRS